CellFace aims to establish digital, holographic flow cytometry as a label-free platform technology for cellular diagnostics. We develop a novel in vitro diagnostic method for cell analysis and biomarkers which are not accessible today for clinical routine.
The vision behind EndoSurg is, to provide physicians with highly specialized tools to perform complex open interventions endoscopically.
We address the crisis of antibiotic resistant bacterial infections by developing a novel class of antibiotics which shows two activities. Our small molecule compound protects the most widely used antibiotics (beta lactams) from resistancae mechanisms and furthermore has a stand-alone antibiotic activity.
Fusix Biotech is a preclinical-stage biotechnology company developing a cutting-edge, next-generation oncolytic virus platform for cancer immunotherapy to treat patients across multiple tumor types.
Invitris aims at curing antibiotic-resistant infections with bacteriophages. To that end, Invitris developed the worldwide first technology to generate bacteriophages in vitro, enabling scalability and cost-efficiency.
We support people to achieve the extraordinary. Our high-tech sensor platform - the N1.System - enables a comprehensive analysis of the human physiology and offers AI-guided performance improvements and rehabilitation of diagnosed deficits.
Stella Medical uses novel computer vision algorithms and a unique user interface to navigate surgical instruments. By using their navigation system, so-called pedicle screws are placed into vertebrae with improved precision.
The Tinus-pillow helps patients with tinnitus and people with sleep disorder to fall asleep with sound - without disturbung the partner sleeping aside. Thanks to the integrated sensors, the user can assess how the music, podcast or audio book has influenced the sleep on the next day and receives suggestions for suitable content.